Explore more publications!
Africa News Observer
Submit Press Release

Africa News Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on October 23, 2025

Stratus and GhostDraft Partner to Bring Advanced Customer Communications Management Solutions to the Insurance Market
October 23, 2025

Stratus and GhostDraft Partner to Bring Advanced Customer Communications Management Solutions to the Insurance Market

Indeterminate EIN Presswire
Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025
October 23, 2025

Updated MDNA11 Clinical Data from the ABILITY-1 Study to be Presented at the European Society for Medical Oncology (ESMO) Immuno-Oncology Congress 2025

Indeterminate GlobeNewswire
Imperial Reports Production for 2025 Third Quarter at Red Chris Mine
October 23, 2025

Imperial Reports Production for 2025 Third Quarter at Red Chris Mine

Indeterminate GlobeNewswire
Century Aluminum Sets Date for Third Quarter 2025 Earnings Announcement
October 23, 2025

Century Aluminum Sets Date for Third Quarter 2025 Earnings Announcement

Indeterminate GlobeNewswire
Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation
October 23, 2025

Qualigen Therapeutics Partners with BitGo to Execute First Multi-Asset C10 Treasury Allocation

Indeterminate GlobeNewswire
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors
October 23, 2025

Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors

Indeterminate GlobeNewswire
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
October 23, 2025

Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules

Indeterminate GlobeNewswire
World YMCA launches global ‘Igniting Youth Futures’ Programme to build a future-ready workforce
October 23, 2025

World YMCA launches global ‘Igniting Youth Futures’ Programme to build a future-ready workforce

Indeterminate EIN Presswire
Fintech With a Conscience: Tunisia’s PAYDAY Takaful Secures Major Backing to Redefine Ethical Finance
October 23, 2025

Fintech With a Conscience: Tunisia’s PAYDAY Takaful Secures Major Backing to Redefine Ethical Finance

Indeterminate EIN Presswire
Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference
October 23, 2025

Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference

Indeterminate GlobeNewswire
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
October 23, 2025

ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference

Indeterminate GlobeNewswire
ATEX Resources Increases Previously Announced Bought Deal Financing to C$96 Million
October 23, 2025

ATEX Resources Increases Previously Announced Bought Deal Financing to C$96 Million

Indeterminate GlobeNewswire
Synfini Selected for SLAS 2026 Innovation AveNEW Showcase
October 23, 2025

Synfini Selected for SLAS 2026 Innovation AveNEW Showcase

Indeterminate GlobeNewswire
Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women
October 23, 2025

Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women

Indeterminate GlobeNewswire
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
October 23, 2025

Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program

Indeterminate GlobeNewswire
Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG
October 23, 2025

Biofrontera Inc. Closes Purchase of All Ameluz® and RhodoLED® US Assets from Biofrontera AG

Indeterminate GlobeNewswire
ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Offers Next-Gen Option as Fully Financed, Permitted Junior
October 23, 2025

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Offers Next-Gen Option as Fully Financed, Permitted Junior

Indeterminate GlobeNewswire
CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath
October 23, 2025

CorMedix Inc. Receives Innovative Technology Designation From Vizient for DefenCath

Indeterminate GlobeNewswire
EBC Financial Group Partners with Match2Pay to Enable Direct Crypto Deposits for Asian Traders
October 23, 2025

EBC Financial Group Partners with Match2Pay to Enable Direct Crypto Deposits for Asian Traders

Indeterminate GlobeNewswire
Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting
October 23, 2025

Crinetics to Highlight Neuroendocrine Tumor Research Progress at the 2025 North American Neuroendocrine Tumor Society Annual Meeting

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions